EUVIMEDAtrasti EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer’s Disease: a Systematic Review of Mechanistic Insights

Sofia Katsigianni, Effrosyni Koutsouraki

Molecular Neurobiology · 2026-01 · 63 (1)

DOI: 10.1007/s12035-026-05914-9 ↗

At a glance

Systematische Übersicht in Molecular Neurobiology, published online on 2026-05-12. Written by Sofia Katsigianni and 1 co-authors. Institution: School of Medicine, Aristotle University, Thessaloniki, Greece. skatsig@auth.gr. Major MEDLINE topics: Alzheimer Disease, Gastrointestinal Microbiome, Dysbiosis, Neuroinflammatory Diseases. Cited 8 times so far (Crossref); 201 references. The full text is freely available (open access, CC BY 4.0). Funded by: Aristotle University of Thessaloniki.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

This systematic review aims to identify microbial species associated with Alzheimer’s disease and clarify how they influence Alzheimer’s disease pathology, including immune system interactions and blood–brain barrier integrity. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 18 studies were analyzed, revealing significant differences in gut microbiota composition between patients with Alzheimer’s disease and controls. Key findings include reduced beneficial bacteria, such as Faecalibacterium prausnitzii and Roseburia hominis and increased pro-inflammatory species like Escherichia coli . Mechanistically, Escherichia coli produces lipopolysaccharides, triggering the release of pro-inflammatory cytokines such as tumor necrosis factor-alpha. This response correlates with elevated YKL-40 levels and reduced beneficial bacteria like Turicibacter . Additionally, reductions in butyrate-producing bacteria impair blood–brain barrier integrity, while bile acid metabolism disruptions impair signaling pathways, exacerbating amyloid-beta aggregation. These findings highlight the interplay between gut microbiota-derived metabolites and neuroinflammation, suggesting that targeting the gut microbiota for novel diagnostic and therapeutic approaches in Alzheimer’s disease.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeDysbiosisNeuroinflammatory DiseasesInflammationHumansAnimals

Author keywords

Alzheimer’s diseaseCognitive declineGut microbiotaGut-brain axisInflammatory signalingNeuroinflammationSCFA

Authors and institutions

  • School of Medicine, Aristotle University, Thessaloniki, Greece. skatsig@auth.gr.
  • School of Medicine, Aristotle University, Thessaloniki, Greece.

Funding

  • Aristotle University of Thessaloniki

Cite

APA

Katsigianni, S., & Koutsouraki, E. (2026). Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer’s Disease: a Systematic Review of Mechanistic Insights. Molecular Neurobiology, 63(1). https://doi.org/10.1007/s12035-026-05914-9

Vancouver

Katsigianni S, Koutsouraki E. Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer’s Disease: a Systematic Review of Mechanistic Insights. Molecular Neurobiology. 2026;63(1). doi:10.1007/s12035-026-05914-9

BibTeX
@article{Katsigianni2026,
  author = {Katsigianni, Sofia and Koutsouraki, Effrosyni},
  title = {Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer’s Disease: a Systematic Review of Mechanistic Insights},
  journal = {Molecular Neurobiology},
  year = {2026},
  volume = {63},
  number = {1},
  doi = {10.1007/s12035-026-05914-9}
}
Start for free →